- Report
- October 2024
- 185 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- December 2024
- 100 Pages
Global
From €5408EUR$5,950USD£4,592GBP
- Report
- March 2025
- 175 Pages
Global
From €4081EUR$4,490USD£3,466GBP
- Report
- August 2024
- 161 Pages
Global
From €2272EUR$2,500USD£1,930GBP
- Report
- January 2025
- 154 Pages
Global
From €2241EUR$2,465USD£1,903GBP
€2636EUR$2,900USD£2,238GBP
- Report
- October 2024
- 182 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- December 2024
- 110 Pages
Global
From €5408EUR$5,950USD£4,592GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1136EUR$1,250USD£965GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1136EUR$1,250USD£965GBP
- Report
- February 2025
- 148 Pages
Global
From €3968EUR$4,365USD£3,369GBP
€4408EUR$4,850USD£3,743GBP
- Report
- November 2024
- 750 Pages
Global
From €1682EUR$1,850USD£1,428GBP
- Report
- November 2024
- 750 Pages
Global
From €1682EUR$1,850USD£1,428GBP
- Report
- February 2025
- 40 Pages
United States
From €1095EUR$1,205USD£930GBP
- Report
- February 2025
- 218 Pages
Global
From €4362EUR$4,799USD£3,704GBP
- Report
- March 2025
- 189 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 199 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 197 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 186 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 190 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 190 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more